SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-007597
Filing Date
2023-03-13
Accepted
2023-03-13 16:45:30
Documents
12
Period of Report
2023-03-13
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K tern-20230313.htm   iXBRL 8-K 54329
  Complete submission text file 0000950170-23-007597.txt   179241

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tern-20230313_pre.xml EX-101.PRE 10683
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tern-20230313_lab.xml EX-101.LAB 14572
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tern-20230313.xsd EX-101.SCH 2478
6 EXTRACTED XBRL INSTANCE DOCUMENT tern-20230313_htm.xml XML 5119
Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Filer) CIK: 0001831363 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39926 | Film No.: 23727891
SIC: 2834 Pharmaceutical Preparations